Form 4: Mirum Pharmaceuticals Executive Peter Radovich Sells Shares to Cover Tax Obligations

Peter Radovich, President and COO of Mirum Pharmaceuticals, sold 2,627 shares of common stock on February 3, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Peter Radovich, the President and COO of Mirum Pharmaceuticals, sold 2,627 shares of the company's common stock on February 3, 2025.
• The sale was executed at a price of $48.2226 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Radovich directly owns 26,961 shares of Mirum Pharmaceuticals.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a stock sale for tax purposes, which is a neutral event.

Industry Context

Executive stock sales are a common occurrence, often related to compensation and tax planning. It's important to consider the size of the sale relative to the executive's total holdings and the overall trading volume of the stock.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders due to the increased supply of shares, but the effect is likely minimal given the relatively small number of shares sold.

Key Dates